Cost-effectiveness of lenalidomide plus low-dose dexamethasone for newly diagnosed multiple myeloma patients ineligible for stem cell transplantation in China.

Conclusion: The cost-effectiveness of Rd relative to BCT for ndMM in Chinese patients is highly attractive. PMID: 31232089 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research